Clinical Trial Update: Lenalidomide and High-Dose Melphalan [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on lenalidomide with high-dose melphalan for patients with multiple myeloma undergoing stem cell transplantation. The Phase 1/2 study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• Revlimid (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma, Stem Cell Transplantation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-06-06